Dizal said that its EGFR inhibitor sunvozertinib has been approved by the FDA for certain types of lung cancer.
READ MOREEli Lilly said it will make the two highest doses of its popular obesity drug Zepbound available to certain patients in cheaper, single-dose vials.
READ MOREEfforts to rein in pharmacy benefit managers, for which drugmakers have been building bipartisan support over the years, were left out of the Senate-passed version of President Donald ...
READ MOREWelcome to Endpoints News’ manufacturing briefs, where we bring you essential news on new builds, collaborations, recalls and more.
READ MORE